Dr. Morgenthau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-5656
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2001 - 2004
- Tel Aviv University SacklerClass of 2001
Certifications & Licensure
- FL State Medical License 2020 - Present
- NY State Medical License 2007 - 2027
- MD State Medical License 2005 - 2007
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis.Ana Devesa, Philip M Robson, Busra Cangut, Ravi Vazirani, Vittoria Vergani
Heart Rhythm. 2024-09-10 - Leveraging AI technology in sarcoidosis.Akiff Premjee, Lawrence Li, Srilakashmi Garikapati, Kwabena Nketiah Sarpong, Adam S Morgenthau
Current Opinion in Pulmonary Medicine. 2024-09-01 - 4 citationsHybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.Maria Giovanna Trivieri, Philip M Robson, Vittoria Vergani, Gina LaRocca, Angelica M Romero-Daza
JACC. Cardiovascular Imaging. 2024-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: